Related Experiment Video
Updated: Nov 15, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Anatomically robust proton therapy using multiple planning computed tomography scans for locally advanced prostate
Kia Busch1,2, Benjamin Dahl1, Stine E Petersen1
1Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.
Anatomically robust proton therapy (ARPT) improved prostate target coverage in locally advanced cancer patients. ARPT plans offered comparable normal tissue sparing to conventional proton therapy while outperforming VMAT in reducing low-to-intermediate dose radiation exposure.
Area of Science:
- Radiation Oncology
- Medical Physics
- Prostate Cancer Treatment
Background:
- Proton therapy (PT) is susceptible to anatomical variations during treatment.
- Pelvic irradiation for locally advanced prostate cancer necessitates robust treatment planning.
Purpose of the Study:
- To evaluate if anatomically robust proton therapy (ARPT) plans improve target coverage and spare normal tissues in prostate cancer patients.
- To compare ARPT with conventional robust PT and VMAT photon plans.
Main Methods:
- ARPT plans were created using patient-specific targets from multiple CT scans.
- Plans were compared against conventional robust PT and VMAT plans.
- Robust optimization with 5mm setup and 3.5% range uncertainty was used.
- Target coverage (V95%, D95%) and normal tissue doses (V5-75Gy) were assessed.
Main Results:
- ARPT significantly improved prostate target coverage for the most challenging patient.
- Mean V95% was 97% for ARPT vs. 95% for conventional robust PT.
- ARPT showed a slight, non-significant increase in normal tissue doses compared to conventional PT.
- ARPT plans significantly reduced low-to-intermediate dose normal tissue exposure compared to VMAT.
Conclusions:
- ARPT enhances target coverage in challenging cases without substantially increasing normal tissue dose compared to conventional PT.
- Both PT techniques reduced low-to-intermediate dose normal tissue exposure versus VMAT.
More Related Videos
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022
09:49A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020